IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,762,000 | -28.3% | 533,301 | -52.9% | 1.98% | -48.1% |
| Q3 2019 | $20,586,000 | -46.2% | 1,131,101 | -27.5% | 3.81% | -54.2% |
| Q2 2019 | $38,234,000 | -7.1% | 1,559,299 | -64.0% | 8.32% | -2.1% |
| Q1 2019 | $41,162,000 | -21.8% | 4,328,303 | -27.3% | 8.50% | +22.7% |
| Q4 2018 | $52,668,000 | -4.3% | 5,951,153 | +21.6% | 6.92% | -14.5% |
| Q3 2018 | $55,062,000 | +3.1% | 4,894,361 | +17.3% | 8.10% | -3.7% |
| Q2 2018 | $53,429,000 | +246.3% | 4,174,105 | +357.2% | 8.41% | +249.9% |
| Q1 2018 | $15,429,000 | -17.6% | 912,987 | -61.0% | 2.40% | -21.5% |
| Q4 2017 | $18,725,000 | -2.9% | 2,340,611 | -5.9% | 3.06% | +7.3% |
| Q3 2017 | $19,279,000 | +15.2% | 2,487,622 | +9.3% | 2.85% | +40.4% |
| Q2 2017 | $16,731,000 | – | 2,276,359 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |